Home NDC 0008-4990
Tygacil
Product NDC 0008-4990
11-digit product format 000084990
Labeler code 0008
Product ID 0008-4990_471458bc-2d5f-470b-a6a4-f4bf0eacf95b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name TIGECYCLINE
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Application NDA021821
Marketing category NDA
Marketing start 2008-06-15
Substance TIGECYCLINE
Active strength 50 mg/5mL
Pharmacologic classes Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Tygacil
Listing expiration 2026-12-31
Active Ingredients# Ingredient, Strength table Ingredient Strength TIGECYCLINE 50 mg/5mL
Harmonized Identifiers# Field, Values table Field Values Unii 70JE2N95KR Rxcui 581531, 584201
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0008-4990-19 Tygacil 5 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 5 50 0008-4990-20 Tygacil 10 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 10 50
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded TIGECYCLINE ACTIVE INGREDIENT 70JE2N95KR TYGACIL (TIGECYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 29 TIGECYCLINE ACTIVE MOIETY 70JE2N95KR TYGACIL (TIGECYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 29 HYDROCHLORIC ACID INACTIVE INGREDIENT QTT17582CB TYGACIL (TIGECYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 29 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X TYGACIL (TIGECYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 29 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I TYGACIL (TIGECYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 29
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0008-4990 TYGACIL (TIGECYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS LLC, A SUBSIDIARY OF PFIZER INC.] 48 Current NDC, Legacy NDC, 2 package rows 20250501_2ccdb48e-c14a-4eeb-348c-4920ccfd7465.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0008-4990-19 00008499019 5 mL in 1 VIAL, SINGLE-DOSE 5 ml Historical 0008-4990-20 00008499020 10 VIAL, SINGLE-DOSE in 1 CARTON (0008-4990-20) / 5 mL in 1 VIAL, SINGLE-DOSE (0008-4990-19) 2009-09-30 0000-00-00 No No Current